Implementing an Effective 
MetS Program

By: Jacqueline Jacques, ND, FTOS, VP of Research and Development, Thorne Research
Friday, July 4, 2014

Metabolic syndrome (MetS), defined by a group of symptoms that together raise the risk of heart disease, diabetes, liver disease and stroke, is becoming a health issue of increasing concern. MetS is tied closely to body weight, so as we see the rate of obesity rising, this syndrome is becoming more and more common. The American Heart Association estimates that 35 percent of U.S. adults have MetS.

The International Diabetes Foundation, the American Heart Association, and the National Heart, Lung, and Blood Institute all define MetS as the presence of at least three of the following symptoms:

  • Increased waist circumference
  • Elevated blood pressure
  • Elevated blood sugar
  • High triglycerides
  • Low high-density lipoprotein (HDL, or “good” cholesterol)

An increase in any one of these measures is a health concern in and of itself; however, a cluster of these symptoms is indicative of future adverse health outcomes when there is no intervention.

Although pharmacology offers effective interventions for many aspects of MetS, the core recommendations for prevention and treatment focus on lifestyle factors that are also good general recommendations for overall health and promoting a healthy weight. These include the following:

  • Weight loss — typically with a goal to reduce weight by as much as 10 percent in six to 12 months
  • Healthy dietary modification — a diet that focuses on lean meats, poultry, fish, colorful fruits and vegetables, whole grains, beans, and low-fat dairy, while at the same time reducing highly processed foods and foods high in fat, sugar and salt
  • Increasing physical activity — with a goal of 20 to 30 minutes of moderate-to-intense exercise daily, or around 150 minutes per week
  • If applicable, stopping smoking

Lifestyle interventions are challenging to implement and manage in a busy practice. Although structured programs have long been available for weight loss, none have focused directly on patient with MetS. In response to the growing need of patients and practitioners to address MetS, Thorne Research has introduced a comprehensive nutrition and lifestyle program to help individuals more easily achieve these health goals.

Thorne Research’s Metabolic Syndrome Program is centered on a flagship product called MediBolic. This product contains vegetarian protein (pea and rice) and a complete multiple vitamin and mineral complex. In addition, each serving of MediBolic contains 10 grams of soluble fiber and an array of nutrients and targeted ingredients to address specific aspects of metabolic syndrome. Thorne Research’s Metabolic Syndrome Program also provides extensive diet and lifestyle tools for dietary modification and stress reduction.

The well-structured Practitioner Guide and Patient Guide make this program simple to introduce and easy for patients to follow.


To learn more about Thorne Research’s Metabolic Syndrome Program, visit www.thorne.com/practitioners/ThorneMetabolicSyndromeProgram.jsp.